Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation.

[1]  C. Mercer,et al.  Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data , 2011, Sexually Transmitted Infections.

[2]  H. Kitchener,et al.  Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England , 2010, British Journal of Cancer.

[3]  M. Jit,et al.  Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. , 2010, Vaccine.

[4]  S. Kerry,et al.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial , 2010, BMJ : British Medical Journal.

[5]  Kurt Straif,et al.  A review of human carcinogens--Part F: chemical agents and related occupations. , 2009, The Lancet. Oncology.

[6]  C. Wheeler,et al.  Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection , 2009, Human vaccines.

[7]  B Romanowski,et al.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women , 2009, The Lancet.

[8]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[9]  M. Plummer,et al.  Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies , 2009, Cancer Epidemiology Biomarkers & Prevention.

[10]  Mark Jit,et al.  Economic evaluation of human papillomavirus vaccination in the United Kingdom , 2008, BMJ : British Medical Journal.

[11]  C. Wheeler,et al.  Human Papillomavirus Genotype Specificity of Hybrid Capture 2 , 2008, Journal of Clinical Microbiology.

[12]  C. Wheeler,et al.  A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus and Cervical Precancer in ASCUS-LSIL Triage Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[13]  P. Castle,et al.  A Comparison of Cervical and Vaginal Human Papillomavirus , 2007, Sexually transmitted diseases.

[14]  M. Jit,et al.  Prevalence of human papillomavirus antibodies in young female subjects in England , 2007, British Journal of Cancer.

[15]  D. Lowy,et al.  Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. , 2007, JAMA.

[16]  F. X. Bosch,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions , 2007 .

[17]  S. Garland,et al.  Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results , 2007, Journal of Clinical Microbiology.

[18]  F. Lunel,et al.  Human Papillomavirus Quantification in Urine and Cervical Samples by Using the Mx4000 and LightCycler General Real-Time PCR Systems , 2007, Journal of Clinical Microbiology.

[19]  Francisco A. R. Garcia,et al.  Pilot Study of a Commercialized Human Papillomavirus (HPV) Genotyping Assay: Comparison of HPV Risk Group to Cytology and Histology , 2006, Journal of Clinical Microbiology.

[20]  J. Peto,et al.  HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial , 2006, British Journal of Cancer.

[21]  Anne M Johnson,et al.  Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection , 2001, The Lancet.

[22]  Wendy Macdowall,et al.  Sexual behaviour in Britain: early heterosexual experience , 2001, The Lancet.

[23]  C. Woodman,et al.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study , 2001, The Lancet.

[24]  J. Sellors,et al.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[25]  N. Kiviat,et al.  Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. , 2000, The Journal of infectious diseases.